AAAAAA

   
Results: 1-7 |
Results: 7
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)
Authors: Stiehm, ER Fletcher, CV Mofenson, LM Palumbo, PE Kang, MH Fenton, T Sapan, CV Meyer, WA Shearer, WT Hawkins, E Fowler, MG Bouquin, P Purdue, L Sloand, EM Nemo, GJ Wara, D Bryson, YJ Starr, SE Petru, A Burchett, S
Citation: Er. Stiehm et al., Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273), J INFEC DIS, 181(2), 2000, pp. 548-554
Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICEexpression in CD34(+) cells
Authors: Sloand, EM Maciejewski, J Kumar, P Kim, S Chaudhuri, A Young, N
Citation: Em. Sloand et al., Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICEexpression in CD34(+) cells, BLOOD, 96(8), 2000, pp. 2635-2639
Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICEexpression in CD34(+) cells
Authors: Sloand, EM Maciejewski, J Kumar, P Kim, S Chaudhuri, A Young, N
Citation: Em. Sloand et al., Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICEexpression in CD34(+) cells, BLOOD, 96(8), 2000, pp. 2735-2739
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo
Authors: Sloand, EM Kim, S Maciejewski, JP Van Rhee, F Chaudhuri, A Barrett, J Young, NS
Citation: Em. Sloand et al., Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo, BLOOD, 95(7), 2000, pp. 2269-2274
Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo
Authors: Sloand, EM Kumar, PN Kim, S Chaudhuri, A Weichold, FF Young, NS
Citation: Em. Sloand et al., Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo, BLOOD, 94(3), 1999, pp. 1021-1027
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Risultati: 1-7 |